Weight, physical activity, diet, and prognosis in breast and gynecologic cancers.

Diet, physical activity, and weight may affect prognosis among women who are diagnosed with breast or gynecologic cancer. Observational studies show associations between being overweight or obese and weight gain with several measures of reduced prognosis in women with breast cancer and some suggestion of poor prognosis in underweight women. Observational studies have shown an association between higher levels of physical activity and improved breast cancer-specific and all-cause mortality, although a dose-response relationship has not been established. One large randomized controlled trial reported increased disease-free survival after a mean of 5 years in patients with breast cancer randomly assigned to a low-fat diet versus control. However, another trial of similar size found no effect from a high vegetable/fruit, low-fat diet on breast cancer prognosis. The few reported studies suggest that obesity negatively affects endometrial cancer survival, while the limited data are mixed for associations of weight with ovarian cancer prognosis. Insufficient data exist for assessing associations of weight, physical activity, or diet with prognosis in other gynecologic cancers. Associations of particular micronutrient intake and alcohol use with prognosis are not defined for any of these cancers. The effects of dietary weight loss and increase in physical activity on survival or recurrence in breast and gynecologic cancers are not yet established, and randomized controlled trials are needed for definitive data.

[1]  S. Graham,et al.  Dietary fat consumption and survival among women with breast cancer. , 1985, Journal of the National Cancer Institute.

[2]  T M Therneau,et al.  Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Winer,et al.  Why women gain weight with adjuvant chemotherapy for breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  F. Speizer,et al.  Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.

[5]  P. Goodwin,et al.  Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Cerhan,et al.  Tamoxifen therapy for breast cancer and endometrial cancer risk. , 1999, Journal of the National Cancer Institute.

[7]  Nagi B. Kumar,et al.  Android obesity at diagnosis and breast carcinoma survival , 2000, Cancer.

[8]  L. J. Costa,et al.  Weight changes during chemotherapy for breast cancer. , 2002, Sao Paulo medical journal = Revista paulista de medicina.

[9]  A. McTiernan,et al.  Weight loss in breast cancer patient management. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  B. Hoffman,et al.  Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study , 2002 .

[11]  Wendy Demark-Wahnefried,et al.  Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Chlebowski,et al.  Breast cancer risk reduction: strategies for women at increased risk. , 2002, Annual review of medicine.

[13]  C. Bain,et al.  Dietary influences on survival after ovarian cancer , 2003, International journal of cancer.

[14]  F. Gilliland,et al.  Adiposity and sex hormones in postmenopausal breast cancer survivors. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Sheps,et al.  Waist-to-hip ratio and breast cancer mortality. , 2003, American journal of epidemiology.

[16]  E. Swisher,et al.  The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. , 2003, Gynecologic oncology.

[17]  E. Mamounas,et al.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. , 2003, Journal of the National Cancer Institute.

[18]  P. Porter,et al.  Epidemiologic and molecular risk factors for contralateral breast cancer among young women , 2003, British Journal of Cancer.

[19]  Tim Byers,et al.  Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.

[20]  C. Rock,et al.  Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Buzdar The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months , 2003, Breast Cancer Research and Treatment.

[22]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Graham A. Colditz,et al.  Physical activity and survival after breast cancer diagnosis , 2005 .

[24]  D. Wickerham,et al.  Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer , 2006, Breast Cancer Research and Treatment.

[25]  N. Boyd,et al.  Weight gain in women with localized breast cancer — a descriptive study , 1988, Breast Cancer Research and Treatment.

[26]  R. Chlebowski,et al.  Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy , 2005, Breast Cancer Research and Treatment.

[27]  C. Ulrich,et al.  Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. , 2005, Obesity research.

[28]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[29]  R. Barakat,et al.  Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma , 2006, Cancer.

[30]  B. Karlan,et al.  Effect of obesity on survival in epithelial ovarian cancer , 2007, Cancer.

[31]  C. Rock,et al.  Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer , 2006, Breast Cancer Research and Treatment.

[32]  C. Rock,et al.  Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  D. Alberts,et al.  Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. , 2007, Gynecologic oncology.

[34]  Loki Natarajan,et al.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. , 2007, JAMA.

[35]  F. Berrino,et al.  Plasma testosterone and prognosis of postmenopausal breast cancer patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  R. Kryscio,et al.  Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. , 2007, Gynecologic oncology.

[37]  B. Asselain,et al.  Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points , 2009, Breast Cancer Research and Treatment.

[38]  B. Sternfeld,et al.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer , 2008, Cancer Causes & Control.

[39]  W. Willett,et al.  Physical Activity and Survival after Diagnosis of Invasive Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[40]  R. Glasspool,et al.  Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  E. Winer,et al.  Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  A. McTiernan,et al.  Mechanisms linking physical activity with cancer , 2008, Nature Reviews Cancer.

[43]  G. Hortobagyi,et al.  Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer , 2008, Clinical Cancer Research.

[44]  C. Rock,et al.  Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[45]  D. Mutch,et al.  Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study. , 2008, Gynecologic oncology.

[46]  R. Baumgartner,et al.  Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  D. Easton,et al.  Risk factors for the incidence of breast cancer: do they affect survival from the disease? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  C. Ulrich,et al.  Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors , 2009, Breast Cancer Research and Treatment.

[49]  K. Courneya,et al.  Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. , 2008, Gynecologic oncology.

[50]  R. Gelber,et al.  The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial , 2009, Breast Cancer Research and Treatment.

[51]  B. Sternfeld,et al.  Physical Activity and Risk of Recurrence and Mortality in Breast Cancer Survivors: Findings from the LACE Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[52]  M. Slattery,et al.  Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  W. Han,et al.  Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  P. Porter,et al.  Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  L. DiPietro,et al.  Randomized Controlled Trial of Aerobic Exercise on Insulin and Insulin-like Growth Factors in Breast Cancer Survivors: The Yale Exercise and Survivorship Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[56]  M. Kemper,et al.  The effect of obesity on survival in patients with ovarian cancer. , 2009, Gynecologic oncology.

[57]  A. Fader,et al.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. , 2009, Gynecologic oncology.

[58]  C. Ulrich,et al.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  N. Chatterjee,et al.  Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  R. Baumgartner,et al.  Associations of insulin resistance and adiponectin with mortality in women with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.